Long sleep duration and frequent day-time naps of the infants can be protective for vigabatrin-induced visual field defects.
作者信息
Ekici Barış, Yıldırım Yeliz, Uçar Didar, Tatlı Burak
机构信息
Department of Pediatric Neurology, Istanbul Medical Faculty, Fatih/Istanbul, Turkey.
出版信息
Ann Indian Acad Neurol. 2012 Oct;15(4):350-1. doi: 10.4103/0972-2327.104359.
Abstract
摘要
相似文献
1
Long sleep duration and frequent day-time naps of the infants can be protective for vigabatrin-induced visual field defects.
Ann Indian Acad Neurol. 2012 Oct;15(4):350-1. doi: 10.4103/0972-2327.104359.
2
Good sleep, bad sleep! The role of daytime naps in healthy adults.
Curr Opin Pulm Med. 2006 Nov;12(6):379-82. doi: 10.1097/01.mcp.0000245703.92311.d0.
3
Visual field defects in patients taking vigabatrin.
Acta Ophthalmol Scand. 2000 Oct;78(5):580-4. doi: 10.1034/j.1600-0420.2000.078005580.x.
4
Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects.
Neurology. 1999 Sep 22;53(5):922-6. doi: 10.1212/wnl.53.5.922.
5
Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
Eye (Lond). 2002 Sep;16(5):567-71. doi: 10.1038/sj.eye.6700168.
6
Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
Acta Neurol Scand Suppl. 2011(192):36-47. doi: 10.1111/j.1600-0404.2011.01599.x.
7
Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy.
Acta Neurol Taiwan. 2006 Dec;15(4):244-50.
8
Reduced sleep duration and daytime naps in pregnant women in Taiwan.
Nurs Res. 2013 Mar-Apr;62(2):99-105. doi: 10.1097/NNR.0b013e3182830d87.
9
Visual field defects associated with vigabatrin therapy.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):716-22. doi: 10.1136/jnnp.67.6.716.
10
The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication.
Eye (Lond). 2005 Jan;19(1):41-4. doi: 10.1038/sj.eye.6701405.
本文引用的文献
1
Visual fields at school-age in children treated with vigabatrin in infancy.
Epilepsia. 2009 Feb;50(2):206-16. doi: 10.1111/j.1528-1167.2008.01961.x.
2
Influence of dietary melatonin on photoreceptor survival in the rat retina: an ocular toxicity study.
Exp Eye Res. 2008 Feb;86(2):241-50. doi: 10.1016/j.exer.2007.10.015. Epub 2007 Nov 5.
3
Vigabatrin and visual field defects in pediatric epilepsy patients.
J Korean Med Sci. 2006 Aug;21(4):728-32. doi: 10.3346/jkms.2006.21.4.728.
4
Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA.
Epilepsia. 2004 Sep;45(9):1043-8. doi: 10.1111/j.0013-9580.2004.01004.x.
5
Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats.
Ann Neurol. 2004 May;55(5):695-705. doi: 10.1002/ana.20081.
6
Visual field constriction in 91 Finnish children treated with vigabatrin.
Epilepsia. 2002 Jul;43(7):748-56. doi: 10.1046/j.1528-1157.2002.17801.x.
7
Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.
Neurology. 2001 Jul 24;57(2):196-200. doi: 10.1212/wnl.57.2.196.
8
Visual field defects with vigabatrin: epidemiology and therapeutic implications.
CNS Drugs. 2001;15(3):217-30. doi: 10.2165/00023210-200115030-00005.
9
Human aging and melatonin. Clinical relevance.
Exp Gerontol. 2001 Jul;36(7):1083-100. doi: 10.1016/s0531-5565(01)00120-6.
10
Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
Neurology. 1996 Dec;47(6):1567-71. doi: 10.1212/wnl.47.6.1567.
Zotero 插件